PDS Biotechnology Post-ASCO Conference Call Tomorrow, June 6, at 8 a.m. ET

FLORHAM PARK, N.J., June 05, 2023 -- PDS Biotechnology Corporation , a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious... | June 5, 2023

Related Keywords

United States ,American ,Deanne Randolph ,Dave Schemelia ,Twitter ,Biotechnology Corporation ,Biotechnology Corporation Nasdaq ,American Society For Clinical Oncology ,Globenewswire Inc ,Clinical Oncology ,Call Information ,Pds Biotechnology Corporation Stock Exchange ,News ,Information ,Press Release ,Florham ,Pune ,023 ,Ads ,Biotechnology ,Corporation ,Immunotherapy ,Company ,Developing ,Rowing ,Pipeline ,F ,Argeted ,Mmunotherapies ,Or ,Dancer ,Nd Pdsb Us70465t1079 ,